Status:
COMPLETED
Osteopathic Treatment and Deep Vein Thrombosis (DVT)
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Deep Vein Thrombosis (DVT)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Osteopathic treatment will provide: 1. A significant reduction of pain and swelling of the affected DVT leg 2. An increase in the quality of life (QOL) for individuals with DVT of the leg 3. Improved...
Detailed Description
Thousands of individuals are affected by deep vein thrombosis (DVT) every year. Medical treatment is aimed at preventing extension and recurrence of the blood clot (DVT) through the use of anticoagula...
Eligibility Criteria
Inclusion
- 18 years of age and older
- first episode of symptomatic objectively confirmed proximal leg DVT without pulmonary embolism
- 1 month of appropriate anticoagulation treatment
- therapeutic level of anticoagulation (ie: Warfarin, INR- 2.0-3.0)
Exclusion
- \> 1 month + 7 days of anticoagulation
- history of previously confirmed proximal or distal leg DVT
- medically unstable individuals requiring hospitalization
- history of peripheral vascular disease (PVD)
- injury of affected leg (trauma within the last 6 months or leg currently casted)
- history of previous stroke
- uncontrolled hypertension
- renal failure requiring hemodialysis or peritoneal dialysis
- diagnosis of cancer in the last five years or currently receiving treatment for cancer
- open heart or vascular surgery in the last year
- any neurological condition (ie: MS, ALS, Parkinsons, etc)
- currently pregnant
- geographic inaccessibility
- unable to provide informed consent
Key Trial Info
Start Date :
November 6 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 4 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02205294
Start Date
November 6 2014
End Date
April 4 2019
Last Update
June 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QEll Health Sciences Centre
Halifax, Nova Scotia, Canada, B3H 1V7